Skip to main content
. Author manuscript; available in PMC: 2023 Nov 28.
Published in final edited form as: Aliment Pharmacol Ther. 2023 Feb 23;57(9):1014–1027. doi: 10.1111/apt.17424

FIGURE 2.

FIGURE 2

Cumulative incidence of death and diseases among NAFLD by BMI category. (A) Cumulative incidence of death by BMI category. (B) Cumulative incidence of type 2 diabetes mellitus by BMI category. (C) Cumulative incidence of any cardiovascular disease by BMI category. (D) Cumulative incidence of cirrhosis by BMI category. (E) Cumulative incidence of any cancer by BMI category. (F) Cumulative incidence of obesity-related cancer by BMI category. *(B–F) Used competing risk analysis.